Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688076'
s Pretax Margin % Range Over the Past 10 Years
Min: -879.03 Med: 17.66 Max: 26.99
Current: 17.29
SHSE:688076's Pretax Margin % is ranked better than 84.48% of 941
companies
in the Biotechnology industry
Industry Median: -89.42
vs SHSE:688076: 17.29
Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Sinopep Allsino Bio Pharmaceutical Co Pretax Margin % Related Terms
Sinopep Allsino Bio Pharmaceutical Co Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinopep Allsino Bio Pharmaceutical Co Pretax Margin % Chart
SHSE:688076 vs VRTX, REGN, ALNY: Pretax Margin % Comparison
For the Biotechnology subindustry, Sinopep Allsino Bio Pharmaceutical Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinopep Allsino Bio Pharmaceutical Co Pretax Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sinopep Allsino Bio Pharmaceutical Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Sinopep Allsino Bio Pharmaceutical Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076) has a Pretax Margin % of 27.21% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Sinopep Allsino Bio Pharmaceutical Co and its competitors. This is 54% above median its historical median of 17.66. According to the industry distribution chart, Sinopep Allsino Bio Pharmaceutical Co ranks #146 out of 941 companies in the Biotechnology industry, placing it in the top 15.5%.
Is Sinopep Allsino Bio Pharmaceutical Co's Pretax Margin % too high?
Sinopep Allsino Bio Pharmaceutical Co's current Pretax Margin % of 27.21% is 54% above median its 10-year median of 17.66. Based on the distribution chart, Sinopep Allsino Bio Pharmaceutical Co ranks #146 out of 941 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Sinopep Allsino Bio Pharmaceutical Co has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sinopep Allsino Bio Pharmaceutical Co's Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sinopep Allsino Bio Pharmaceutical Co ranks #146 out of 941 companies for Pretax Margin %. This places Sinopep Allsino Bio Pharmaceutical Co in the top 16% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Sinopep Allsino Bio Pharmaceutical Co and its competitors. Sinopep Allsino Bio Pharmaceutical Co's current Pretax Margin % is 27.21%, which is 54% above median its own 10-year median of 17.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinopep Allsino Bio Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥58.87, compared to a current price of ¥28.00 — trading 52.4% below its estimated fair value. The current Pretax Margin % is 27.21%, which is 54% above median its 10-year median of 17.66. Sinopep Allsino Bio Pharmaceutical Co's overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076), the current Pretax Margin % is 27.21% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076) Overvalued in 2026?
Based on GuruFocus' analysis, Sinopep Allsino Bio Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥28.00 is trading 52.4% below its estimated GF Value™ of ¥58.87.
GuruFocus considers Sinopep Allsino Bio Pharmaceutical Co to be Significantly Undervalued.
Key valuation signals for SHSE:688076:
Pretax Margin %: 27.21% (54% above median its 10-year median of 17.66)
GF Value™: ¥58.87 vs. price of ¥28.00 (52.4% below fair value)
No single metric tells the full story. See the SHSE:688076 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sinopep Allsino Bio Pharmaceutical Co Business Description
Sinopep Allsino Bio Pharmaceutical Co Ltd is a market-oriented, research and development and innovation-driven biomedical enterprise focusing on the research, development, production and sales of peptide drugs and small molecule chemical drugs.
65GF Score
Get the complete analysis for SHSE:688076
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688076 has been successfully added to your 
